Oric Pharmaceuticals (ORIC) Stock Chart & Stock Price History $9.74 +0.05 (+0.52%) Closing price 04:00 PM EasternExtended Trading$9.73 -0.01 (-0.10%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Oric Pharmaceuticals Stock Price Performance The Oric Pharmaceuticals (ORIC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 5.98%, with a year-to-date return of 20.69%. In the past month, the stock has decreased 12.65%, reflecting recent market activity. As of the latest close, Oric Pharmaceuticals traded at $9.69 with a market cap of $941.09 million and volume of 353,405 shares. Five years ago, the stock traded at $24.29, representing a 59.90% decrease over that period. At the time, it had a market cap of $759.09 million and a volume of 88,400 shares. Receive ORIC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oric Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.83%1 Month Performance-12.65%3 Month Performance+63.70%Year-To-Date Performance+20.69%1 Year Performance+5.98%5 Year Performance-59.90% ORIC Stock Chart for Friday, August, 22, 2025 ORIC Chart by TradingView Oric Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$9.51$9.69+1.89%$9.77$9.32353,405 shs$941.09 million08/20/2025$9.60$9.51-0.94%$9.64$9.36505,886 shs$923.64 million08/19/2025$9.90$9.60-3.03%$9.96$9.51826,389 shs$932.35 million08/18/2025$9.66$9.90+2.48%$10.05$9.67870,992 shs$961.49 million08/15/2025$9.93$9.66-2.72%$10.06$9.54650,938 shs$938.18 million08/14/2025$9.83$9.93+1.02%$9.96$9.37802,062 shs$846.27 million08/13/2025$9.52$9.83+3.26%$10.31$9.56932,643 shs$837.71 million08/12/2025$9.20$9.52+3.48%$9.66$9.20490,000 shs$811.29 million08/11/2025$9.24$9.20-0.43%$9.30$8.97852,213 shs$784.02 million08/08/2025$9.63$9.24-4.05%$9.66$9.031.05 million shs$787.43 million Get the Latest News and Ratings for ORIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oric Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$9.88$9.63-2.53%$9.93$9.52496,403 shs$820.71 million08/06/2025$9.99$9.88-1.10%$9.97$9.47852,179 shs$841.97 million08/05/2025$9.74$9.99+2.57%$10.05$9.55715,505 shs$851.35 million08/04/2025$10.12$9.74-3.75%$10.31$9.72819,738 shs$830.08 million08/01/2025$9.97$10.12+1.50%$10.14$9.63942,341 shs$862.47 million07/31/2025$10.71$9.97-6.91%$10.76$9.88893,777 shs$849.64 million07/30/2025$11.04$10.71-2.99%$11.33$10.54882,486 shs$912.71 million07/29/2025$11.18$11.04-1.25%$11.62$10.0012.36 million shs$940.87 million07/28/2025$11.44$11.18-2.27%$11.60$11.12637,288 shs$952.76 million07/25/2025$11.73$11.44-2.47%$11.69$11.21458,960 shs$974.92 million07/24/2025$11.80$11.73-0.59%$11.91$11.53287,772 shs$999.63 million07/23/2025$11.15$11.80+5.83%$12.00$11.19862,887 shs$1.01 billion07/22/2025$11.06$11.15+0.81%$11.40$11.02552,486 shs$950.20 million07/21/2025$11.01$11.06+0.45%$11.39$11.00543,561 shs$942.53 million Related Companies Apellis Pharmaceuticals Stock Chart Scholar Rock Stock Chart Mirum Pharmaceuticals Stock Chart MorphoSys Stock Chart NewAmsterdam Pharma Stock Chart AMNEAL PHARMACEUTICALS Stock Chart Ultragenyx Pharmaceutical Stock Chart Kymera Therapeutics Stock Chart Immunovant Stock Chart HUTCHMED Stock Chart Receive ORIC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oric Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORIC) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oric Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oric Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access